Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2331]

Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives

Colorectal cancer in sub-Saharan Africa: Lack of basic care is costing lives

Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus cancers

Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus...

FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma

FDA approves pembrolizumab with chemotherapy for HER2-negative gastric or gastroesophageal junction adenocarcinoma

More than 10% of samples from a stool-based colorectal cancer test may be unsatisfactory

More than 10% of samples from a stool-based colorectal cancer test may be unsatisfactory

Some increase in cancer after 1986 Chernobyl disaster

Some increase in cancer after 1986 Chernobyl disaster

FDA amends pembrolizumab’s gastric cancer indication

FDA amends pembrolizumab’s gastric cancer indication

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

FDA approves pembrolizumab with chemotherapy for biliary tract cancer

Does diabetes affect the survival of individuals with colorectal cancer?

Does diabetes affect the survival of individuals with colorectal cancer?

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at high-risk of recurrence

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients at...

ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds

ESMO 2023: Dual-action drug produces positive results in patients with advanced neuroendocrine tumours, trial finds

More from ecancer